Search

everythinglearnresearchcommunity

for

Search:↓

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Nilotinib can cause keratosis pilaris, a skin condition.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

JAK inhibitors show promise for treating skin diseases effectively and safely.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

These medications for BPH have known risks and may have new side effects.

Small KP peptide improves hair without reducing agents, while larger proteins need them for better results.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

JAK inhibitors may reduce depression in people with alopecia areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Cadd4 effectively reduces cholesterol levels without side effects.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.